Method of orally treating inflammatory skin conditions with prodrugs of 5-fluorouracil
US7026301B2 · kind B2 · utility
7Cited by
4References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 2003 |
| Grant date | Apr 11, 2006 |
| Priority date | — |
| Expiry date | Mar 5, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/513
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the treatment of inflammatory skin conditions, including psoriasis, with a prodrug of 5-fluorouracil. The invention relates to methods for treatment of psoriasis with capecitabine, an oral prodrug of 5-fluorouracil.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.